QQ客服 官方微博 反馈留言

	Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study
	Wu, Yi-Long; Lu, Shun; Cheng, Ying; Zhou, Caicun; Wang, Jie; Mok, Tony; Zhang, Li; Tu, Haiyan; Wu, Lin; Feng, Jifeng
	2018
卷号	78
期号	13
会议录	CANCER RESEARCH
语种	英语
URL标识	查看原文
ISSN号	0008-5472
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/3609155
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wu, Yi-Long,Lu, Shun,Cheng, Ying,et al. Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study[C]. 见:.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。